The hospital highlights that the Biobank reflects its commitment to innovation and research leadership, reinforcing Saudi Arabia’s position in advancing personalized medicine and future-oriented healthcare solutions. By integrating advanced technologies, the Biobank enables precision therapies, enhances patient outcomes, and contributes to groundbreaking clinical and academic research.
Distinguished by advanced specifications and capacity, the Biobank is designed to store up to 10 million high-quality biospecimens, including liquid biopsies, fresh tissue, and blood derivatives. These resources are managed through secure and integrated electronic systems, safeguarding patient data while enabling innovation in preventive, predictive, and participatory care.
The center also plays a pivotal role in monitoring and addressing complex diseases such as cancer, cardiovascular conditions, neurological disorders, diabetes, rare diseases, and ageing-related health issues. Rigorous governance structures ensure patient rights and privacy are protected, while supporting the broader medical research community and stakeholders.
It is noteworthy that KFSHRC has been ranked 20th globally on the list of the world’s top 250 Academic Medical Centres for the second consecutive year. Newsweek magazine recognized KFSHRC among the world’s best 250 hospitals and included it in the World’s Best Smart Hospitals list for 2025.
For more information, please visit www.kfshrc.edu.sa or contact our media team at mediacoverage@kfshrc.edu.sa
.
ٍٍRiyadh
King Faisal Specialist Hospital & Research Centre
email us here
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
About The Author
